Abstract
The clinical value of 11C-Choline-PET is reviewed by using previously published articles with significant evidence levels. This meta-analysis indicates that 11C-Choline-PET showed a high ability for the diagnosis of primary tumor, clinical staging and detection of recurrence. Especially, in patients with suspected metastasis or recurrence, 11C-Choline-PET was able to detect foci of diseases, which were not evident by morphological imaging modalities. Thus, 11C-Choline-PET may have a potential to afford important information for the management of such patients and yield cost-effectiveness by obviating unnecessary examinations.
